Literature DB >> 2340610

Atropine-induced heart rate changes: a comparison between midazolam-fentanyl-propofol-N2O and midazolam-fentanyl-thiopentone-enflurane-N2O anaesthesia.

G Cross1, D Gaylard, M Lim.   

Abstract

Atropine-induced heart rate (HR) changes were studied in 19 patients (ASA physical status I) during anaesthesia-maintained predominantly with propofol-N2O or thiopentone-enflurane-N2O. Ten patients (Group A) received midazolam (0.07 mg.kg-1), fentanyl (1 microgram.kg-1), propofol (2 mg.kg-1) and succinylcholine (1 mg.kg-1). Following tracheal intubation, anaesthesia was maintained with propofol (6 mg.kg-1.hr-1), N2O (67 per cent) and O2 (33 per cent). In nine patients (Group B) thiopentone (4 mg.kg-1) was substituted for propofol and anaesthesia maintained with N2O (67 per cent) O2 (33 per cent), and enflurane (0.5 per cent inspired concentration). The study was non-randomised because Group B patients were only included if HR before administration of atropine less than 90 beats.min-1. IPPV was performed in all patients using a Manley ventilator (minute vol. 85 ml.kg-1; tidal vol. 7 ml.kg-1). Ten minutes after tracheal intubation, incremental doses of atropine (equivalent cumulative doses: 1.8, 3.6, 7.2, 14.4, 28.8 micrograms.kg-1) were administered at two-minute intervals and HR responses calculated during the last 45 sec of each intervening period. No differences were observed between the groups following 1.8 and 3.6 micrograms.kg-1 atropine, but propofol-N2O anaesthesia was associated with reduced responses (P less than 0.01) following 7.2, 14.4 and 28.8 micrograms.kg-1 atropine. These results suggest that there is a predominance of parasympathetic influences during propofol-N2O anaesthesia compared with thiopentone-enflurane-N2O anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2340610     DOI: 10.1007/BF03005617

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  10 in total

Review 1.  Adverse effects of neuromuscular blocking drugs.

Authors:  J M Hunter
Journal:  Br J Anaesth       Date:  1987-01       Impact factor: 9.166

Review 2.  Anticholinergic drugs and anaesthesia.

Authors:  R K Mirakhur
Journal:  Can J Anaesth       Date:  1988-09       Impact factor: 5.063

3.  Infusions of propofol to supplement nitrous oxide-oxygen for the maintenance of anaesthesia. A comparison with halothane.

Authors:  J W Sear; I Shaw; A Wolf; N H Kay
Journal:  Anaesthesia       Date:  1988-03       Impact factor: 6.955

4.  Haemodynamic changes during anaesthesia induced and maintained with propofol.

Authors:  M A Claeys; E Gepts; F Camu
Journal:  Br J Anaesth       Date:  1988-01       Impact factor: 9.166

Review 5.  Enflurane in clinical practice.

Authors:  A P Adams
Journal:  Br J Anaesth       Date:  1981       Impact factor: 9.166

6.  Heart rate response to atropine in humans anaesthetized with five different techniques.

Authors:  H Yamaguchi; S Dohi; S Sato; H Naito
Journal:  Can J Anaesth       Date:  1988-09       Impact factor: 5.063

7.  Dose requirements of propofol by infusion during nitrous oxide anaesthesia in man. I: Patients premedicated with morphine sulphate.

Authors:  K R Spelina; D P Coates; C R Monk; C Prys-Roberts; I Norley; M J Turtle
Journal:  Br J Anaesth       Date:  1986-10       Impact factor: 9.166

8.  Effect of propofol anesthesia on baroreflex activity in humans.

Authors:  P M Cullen; M Turtle; C Prys-Roberts; W L Way; J Dye
Journal:  Anesth Analg       Date:  1987-11       Impact factor: 5.108

9.  Haemodynamic effects of infusions of diisopropyl phenol (ICI 35 868) during nitrous oxide anaesthesia in man.

Authors:  C Prys-Roberts; J R Davies; R K Calverley; N W Goodman
Journal:  Br J Anaesth       Date:  1983-02       Impact factor: 9.166

10.  Central vagal control of fentanyl-induced bradycardia during halothane anesthesia.

Authors:  J A Reitan; K B Stengert; M L Wymore; R W Martucci
Journal:  Anesth Analg       Date:  1978 Jan-Feb       Impact factor: 5.108

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.